Structure-activity relationship of suramin and pyridoxal-5′-phosphate derivatives as P2 receptor antagonists

Current Pharmaceutical Design

Volumn 8, Issue 26, 2002, Pages 2371-2399

  Lambrecht, Günter ^a   Braun, Kirsten ^a   Damer, Susanne ^a   Ganso, Matthias ^a   Hildebrandt, Caren ^a   Ullmann, Heiko ^a   Kassack, Matthias U ^a   Nickel, Peter ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 6 N (2 METHYLTHIOETHYL) 2 (3,3,3 TRIFLUOROPROPYLTHIO)ADENOSINE PHOSPHATE; ADENINE; ADENOSINE DIPHOSPHATE; BRILLIANT BLUE; CIBACRON BLUE F3GA; CYCLIC PYRIDOXINE ALPHA 4,5 MONOPHOSPHATE 6 PHENYLAZO 2',5' DISULFONIC ACID; DIINOSINE PENTAPHOSPHATE; EVANS BLUE; MRS 2220; NF 023; NF 279; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL 5 PHOSPHATE 6 (2' NAPHTHYLAZO 6' NITRO 4',8' DISULFONIC ACID); PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXALPHOSPHATE 6 AZOPHENYL 2',5' DISULFONIC ACID; PYRIDOXAMINE PHOSPHATE; PYRIDOXINE; PYRIMIDINE NUCLEOTIDE; SB 9; SULFONIC ACID DERIVATIVE; SURAMIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; ONCHOCERCIASIS; PHENOTYPE; PRIORITY JOURNAL; RAT; REVIEW; STRUCTURE ACTIVITY RELATION; TRYPANOSOMIASIS; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; METABOLISM;

ANIMALS; HUMANS; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; STRUCTURE-ACTIVITY RELATIONSHIP; SURAMIN;

EID: 0036025118     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612023392973     Document Type: Review

References (220)

1. Ralevic, V., Burnstock, G. Pharmacol. Rev. 1998, 50, 413.
2. Lambrecht, G. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 340.
3. Zimmermann, H. Drug Dev. Res. 1996, 39, 337.
4. Zimmermann, H. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 299.
5. Klotz, K.N. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 382.
6. Fredholm, B.B., Arslan, G., Halldner, L., Kull, B., Schulte, G., Wasserman, W. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 364.
7. Müller, C.E. Curr. Med. Chem. 2000, 7, 1269.
8. Lambrecht, G., Damer, S., Niebel, B., Czeche, S., Nickel, P., Rettinger, J., Schmalzing, G., Mutschler, E. Prog. Brain Res. 1999, 120, 107.
9. Abbracchio, M.P., Williams, M. Purinergic and Pyrimidinergic Signalling, Handbook of Experimental Pharmacology, Springer-Verlag: Berlin, 2001, Vol. 151/I and 151/II.
10. Dalziel, H.H. , Westfall, D.P. Pharmacol. Rev. 1994, 46, 449.
11. Abbracchio, M.P., Burnstock, G. Pharmac. Ther. 1994, 64, 445.
12. Nicke, A., Rettinger, J., Büttner, C., Eichele, A., Lambrecht, G., Schmalzing, G. Prog. Brain Res. 1999, 120, 61.
13. North, R.A., Surprenant, A. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 563.
14. Chessell, I.P., Michel, A.D., Humphrey, P.P.A. In Purinergic and Pyrimidinergic Signalling I. Handbook of Experimental Pharmacology, Abbracchio, Williams, Eds., Springer-Verlag: Berlin, 2001, Vol. 151/I, pp. 47-63.
15. Khakh, B.S., Burnstock, G., Kennedy, C., King, B.F., North, R.A., Seguela, P., Voigt, M., Humphrey, P.P.A. Pharmacol. Rev. 2001, 53, 107.
16. MacKenzie, A.B., Surprenant, A., North, R.A. Ann. N.Y. Acad. Sci, 1999, 868, 716.
17. Nicke, A., Bäumert, H.G., Rettinger, J., Eichele, A., Lambrecht, G., Mutschler, E., Schmalzing, G. EMBO J. 1998, 17, 3016.
18. Rettinger, J., Aschrafi, A., Schmalzing, G. J .Biol. Chem. 2000, 275, 33542.
19. Stoop, R., Thomas, S., Rassendren, F., Kawashima, E., Buell, G., Surprenant, A., North, R.A. Mol. Pharmacol. 1999, 56, 973.
20. Jiang, L.H., Rassendren, F., Surprenant, A., North, R.A. J. Biol. Chem. 2000, 275, 34190,
21. Ennion, S., Hagan, S., Evans, R.J. J. Biol. Chem. 2000, 275, 29361.
22. Egan, T.M., Haines, W.R., Voigt, M.M. J. Neurosci. 1998, 18, 2350.
23. Rassendren, F., Buell, G., Newbolt, A., North, R.A., Surprenant, A. EMBO J. 1997, 16, 3446.
24. Jiang, L.H., Rassendren, F., Spelta, V., Surprenant, A., North, R.A. J. Biol. Chem. 2001, 276, 14902.
25. Nörenberg, W., Illes, P. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 324.
26. King, B.F., Townsend-Nicholson, A., Wildman, S.S., Thomas, T., Spyer, K.M., Burnstock, G. J. Neurosci. 2000, 20, 4871.
27. Liu, M., King, B.F., Dunn, P.M., Rong, W., Townsend-Nicholson, A., Burnstock, G. J. Pharmacol. Exp. Ther. 2001, 296, 1043.
28. Gu, B.J., Zhang, W., Worthington, R.A., Sluyter, R., Dao-Ung, P., Petrou, S., Barden, J.A., Wiley, J.S. J. Biol. Chem. 2001, 276, 11135.
29. Jones, C.A., Chessell, I.P., Simon, J., Barnard, E.A., Miller, K.J., Michel, A.D., Humphrey, P.P.A. Br. J. Pharmacol. 2000, 129, 388.
30. Hibell, A.D., Thompson, K.M., Xing, M., Humphrey, P.P.A., Michel, A.D. J. Pharmacol. Exp. Ther. 2001, 296, 947.
31. Brinson, A.E., Harden, T.K. J. Biol. Chem. 2001, 276, 11939.
32. Von Kügelgen, I., Wetter, A. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 310.
33. Barnard, E.A., Simon, J., Webb,.T.E. Mol. Neurobiol. 1997, 15, 103.
34. Boarder, M.R., Webb, T.E. In Purinergic and Pyrimidinergic Signalling I. Handbook of Experimental Pharmacology, Abbracchio, Williams, Eds., Springer-Verlag: Berlin, 2001, Vol. 151/I, pp. 65-88.
35. Filtz, T.M., Harden, T.K., Nicholas, R.A. In Purinergic Approaches in Experimental Therapeutics, Jacobson, Jarvis, Eds., Wiley-Liss: New York, 1997, pp. 39-53.
36. Communi, D., Govaerts, C., Parmentier, M., Boeynaems, J.M. J. Biol. Chem. 1997, 272, 31969.
37. Hollopeter, G., Jantzen, H.M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.B., Nurden, P., Nurden, A., Julius, D., Conley, P.B. Nature 2001, 409, 202.
38. Erb, L., Garrad, R., Wang, Y., Quinn, T., Turner, J.T., Weisman, G.A. J. Biol. Chem. 1995, 270, 4185.
39. Jiang, Q., Guo, D., Lee, B.X., Van Rhee, A.M., Kim, Y.C., Nicholas, R.A., Schachter, J.B., Harden, T.K., Jacobson, K.A. Mol. Pharmacol. 1997, 52, 499.
40. Moro, S., Guo, D., Camaioni, E., Boyer, J.L., Harden, T.K., Jacobson, K.A. J. Med. Chem. 1998, 41, 1456.
41. Qi, A.D., Kennedy, C., Harden, T.K., Nicholas, R.A. Br. J. Pharmacol. 2001, 132, 318.
42. Communi, D., Robaye, B., Boeynaems, J.M. Br. J. Pharmacol. 1999, 128, 1199.
43. Van der Weyden, L., Adams, D.J., Luttrell, B.M., Conigrave, A.D., Morris, M.B. Mol. Cell. Biochem. 2000, 213, 75.
44. Savi, P., Labouret, C., Delesque, N., Guette, F., Lupker, J., Herbert, J.M. Biochem. Biophys. Res. Commun. 2001, 283, 379.
45. Robertson, S.J., Ennion, S.J., Evans, R.J., Edwards, F.A. Curr. Opin. Neurobiol. 2001, 11, 378.
46. Torres, G.E., Egan, T.M., Voigt, M.M. J. Biol. Chem. 1999, 274, 22359.
47. Communi, D., Janssens, R., Suarez-Huerta, N., Robaye, B., Boeynaems, J.M. Cell. Signal. 2000, 12, 351.
48. Kennedy, C., Qi, A.D., Herold, C.L., Harden, T.K., Nicholas, R.A. Mol. Pharmacol. 2000, 57, 926.
49. Suarez-Huerta, N., Pouillon, V., Boeynaems, J.M., Robaye, B. Eur. J. Pharmacol. 2001, 416, 197.
50. Janssens, R., Paindavoine, P., Parmentier, M., Boeynaems, J.M. Br. J. Pharmacol. 1999, 126, 709.
51. Rana, B.K., Shiina, T., Insel, P.A. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 593.
52. Li, Q., Olesky, M., Palmer, R.K., Harden, T.K., Nicholas, R.A. Mol. Pharmacol. 1998, 54, 541.
53. Boyer, J.L., Delaney, S.M., Villanueva, D., Harden, T.K. Mol. Pharmacol. 2000, 57, 805.
54. Bogdanov, Y.D., Dale, L., King, B.F., Whittock, N., Burnstock, G. J. Biol. Chem. 1997, 272, 12583.
55. King, B.F., Townsend-Nicholson, A., Burnstock, G. Trends Pharmacol. Sci. 1998, 19, 506.
56. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J.M., Morelli, A., Torboli, M., Bolognesi, G., Baricordi, OR. Blood 2001, 97, 587.
57. Dunn, P.M., Zhong, Y., Burnstock, G. Prog. Neurobiol. 2001, 65, 107.
58. Barnard, E.A., Simon, J. Trends Pharmacol. Sci. 2001, 22, 388.
59. Takasaki, J., Kamohara, M., Saito, T., Matsumoto, M., Matsumoto, S.-I, Ohishi, T., Soga, T., Matsushime, H,, Furuichi, K. Mol. Pharmacol. 2001, 60, 432.
60. Nicholas, R.A. Mol. Pharmacol. 2001, 60, 416.
61. Zhang, F.L., Luo, L., Gustafson, E., Lachowicz, J., Smith, M., Qiao, X., Liu, Y.-H., Chen, G., Pramanik, B., Laz, T.M.,. Palmer, K., Bayne, M., Monsma Jr., F.J. J. Biol, Chem. 2001, 276, 8608.
62. Lewis, C.J., Evans, R.J. J. Vasc. Res. 2001, 38, 332.
63. Migita, K., Haines, W.R., Voigt, M.M., Egan, T.M. J. Biol. Chem. 2001, 276, 30934.
64. Haines, W.R., Migita, K., Cox, J.A., Egan, T.M., Voigt, M.M. J. Biol. Chem. 2001, 2 76, 32793.
65. Haines, W.R., Voigt, M.M., Migita, K., Torres, G.E., Egan, T.M. J. Neurosci. 2001, 21, 5885.
66. Virginio, C., North, R.A., Surprenant, A. J. Physiol. 1998, 510, 27.
67. Evans, R.J., Surprenant, A. Semin. Neurosci. 1996, 8, 217.
68. Braun, K., Rettinger, J., Ganso, M., Kassack, M., Hildebrandt, C., Ullman H., Nickel, P., Schmalzing, G., Lambrecht, G. Naunyn-Schmiedeberg's Arch. Pharmacol. 2001, 364, 285.
69. Surprenant, A., Schneider, D.A., Wilson, H.L., Galligan, J.J., North, R.A. J. Auton. Nerv. Sys. 2000, 81, 249
70. Mulryan, K., Gitterman, D.P., Lewis, C.J., Vial, C., Lackle, B.J., Cobb, A.L., Brown, J.E., Conley, E.C., Buell, G., Pritchard, C.A., Evans, R.J. Nature, 2000, 403, 86.
71. Vial, C., Evans, R.J. Br. J. Pharmacol. 2000, 131, 1489.
72. Vlaskovska, M., Kasakov, L., Rong, W., Bodin, P., Bardini, M., Cockayne, D.A., Ford, A.P.D.W., Burnstock, G. J. Neurosci. 2001, 21, 5670.
73. Cockayne, D.A., Hamilton, S.G., Zhu, Q.-M., Dunn, P.M., Zhong, Y., Novakovic, S., Malmberg, A.B., Cain, G., Berson, A., Kassotakis, L., Hedley, L., Lachnit, W.G., Burnstock, G., McMahon, S.B., Ford, A.P.D.W. Nature 2000, 407, 1011.
74. Souslova, V., Cesare, P., Ding, Y., Akopian, A.N., Stanfa, L., Suzuki, R., Carpenter, K., Dickenson, A., Boyce, S., Hill, R., Nebenius-Oosthuizen, D., Smith, A.J.H., Kidd, E.J., Wood, J.N. Nature 2000, 407, 1015.
75. Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N., Koller, B.H., Griffiths, R.J., Gabel, C.A. J. Biol. Chem. 2001, 276, 125.
76. Fabre, J.E., King, B.F., Koller, B.H. Drug Dev. Res. 2001, 52, 150.
77. Léon, C., Freund, M., Ravanat, C., Baurand, A., Cazenave,, J.-P., Gachet, C. Circulation 2001, 103, 718.
78. Léon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J.-P., Gachet, C. J Clin. Invest. 1999, 104, 1731.
79. Fabre, J.-E., Nguyen, M.T., Latour, A., Keifer, J.A., Audoly, L.P., Coffman, T.M., Koller, B.H. Nat. Med. 1999, 5, 1199.
80. Homolya L., Watt, W.C., Lazarowski, E.R., Koller, B.H., Boucher, R.C. J. Biol. Chem. 1999, 274, 26454.
81. Cressman V.L., Lazarowski, E., Homolya, L., Boucher, R.C., Koller, B.H., Grubb, B.R. J. Biol. Chem. 1999, 274, 26461.
82. Burnstock, G., Fischer, B., Hoyle, C.H.V., Maillard, M., Ziganshin, A.U., Brizzolara, A.L., von Isakovics, A., Boyer, J.L., Harden, T.K., Jacobson, K.A. Drug Dev. Res. 1994, 31, 206.
83. Jacobson, K.A., Kim, Y.-C., Camaioni, E., van Rhee, A.M. In The P2 Nucleotide Receptors, Turner, Weisman, Fedan, Eds., Humana Press Inc.: Totowa, NJ, 1998, pp. 81-107.
84. Jacobson K.A., Knutsen, L.J.S. In Purinergic and Pyrimidinergic Signalling I. Handbook of Experimental Pharmacology, Abbracchio, Williams, Eds., Springer-Verlag: Berlin, 2001, Vol. 151/I, pp. 129-175.
85. Jacobson, K.A., Suzuki, F. Drug Dev. Res. 1996, 39, 289.
86. Cusack, N.J. Drug Dev. Res. 1993, 28, 244.
87. Pendergast, W., Yerxa, B.R., Douglass, III, J.G., Shaver, S.R., Dougherty, R.W., Redick, C.C., Sims, I.F., Rideout, J.L. Bioorg. Med. Chem. Lett. 2001, 11, 157.
88. Fischer, B. Exp. Opin. Ther. Patents 1999, 9, 385.
89. Fischer, B. Drug Dev. Res. 2000, 50, 338.
90. Guile, S.D., Ince, F., Ingall, A.H., Kindon, N.D., Meghani, P., Mortimore, M.P. Prog. Med. Chem. 2001, 38, 115.
91. Hoyle, C.H.V., Hilderman, R.H., Pintor, J.J., Schluter, H., King, B.F. Drug Dev. Res. 2001, 52, 260.
92. Fischer, B., Yefidoff, R., Major, D.T., Rutman-Halili, I., Shneyvays, V., Zinman, T., Jacobson, K.A., Shainberg, A. J. Med. Chem. 1999, 42, 2685.
93. Malmsjö, M., Hou, M., Harden, T.K., Pendergast, W., Pantev, E., Edvinsson, L., Erlinge, D. J. Pharmacol. Exp. Ther. 2000, 293, 755.
94. Malmsjö, M., Adner, M., Harden, T.K., Pendergast, W., Edvinsson, L., Erlinge, D. Br. J. Pharmacol. 2000, 131, 51.
95. Bo, X., Fischer, B., Maillard, M., Jacobson, K.A., Burnstock, G. Br. J. Pharmacol. 1994, 112, 1151.
96. Michel, A.D., Lundström, K., Buell, G.N., Surprenant, A., Valera, S., Humphrey, P.P.A. Br. J. Pharmacol. 1996, 117, 1254.
97. Michel, A.D., Grahames, C.B.A., Humphrey, P.P.A. Naunyn-Schmiedeberg's Arch. Pharmacol. 1996, 354, 562.
98. Yu, H., Bianchi, B., Metzger, R., Lynch, K.J., Kowaluk, E.A., Jarvis, M.F., van Biesen, T. Drug Dev. Res. 1999, 48, 84.
99. Filtz, T.M., Li, Q., Boyer, J.L., Nicholas, R.A., Harden, T.K. Mol. Pharmacol. 1994, 46, 8.
100. Mahaut-Smith, M.P., Ennion, S.J., Rolf, M.G., Evans, R.J. Br. J. Pharmacol. 2000, 131, 108.
101. Teixeira, M., Ferrary, E., Butlen, D. Am. J. Physiol. 2000, 279, R803.
102. Schäfer, R., Reiser, G. Neurochem. Int. 1999, 34, 303.
103. Verspohl, E.J., Johannwille, B., Kaiserling-Buddemeier, I., Schlüter, H., Hagemann, J. J. Pharm. Pharmacol. 1999, 51, 1175.
104. Baurand, A., Raboisson, P., Freund, M., Léon, C., Cazenave, J.-P., Bourguignon, J.-J., Gachet, C. Eur. J. Pharmacol. 2001, 412, 213.
105. Oaknin, S., Rodriguez- Ferrer, C.R., Aguilar, J.S., Ramos, A., Rotllán, P. Neurosci. Lett. 2001, 309, 177.
106. Jin, J., Tomlinson, W., Kirk, I.P., Kim, Y.B., Humphries, R.G., Kunapuli, S.P. Br. J. Pharmacol. 2001, 133, 521.
107. Fagura, M.S., Jarvis, G.E., Dougall, I.G., Leff, P. J. Auton. Nerv. Sys. 2000, 81, 178.
108. Jacobson, K.A., Hoffmann, C., Kim, Y.-C., Camaioni, E., Nandanan, E., Jang, S.Y., Guo, D.-P., Ji, X.-d., von Kügelgen, I., Moro, S., Ziganshin, A.U., Rychkov, A., King, B.F., Brown, S.G., Wildman, S.S., Burnstock, G., Boyer, J.L., Mohanram, A., Harden, T.K. Prog. Brain Res. 1999, 120, 119.
109. Soto, F., Garcia-Guzman, M., Stühmer, W. J. Membrane Biol. 1997, 160, 91.
110. Bhagwat, S.S., Williams, M. Eur. J. Med. Chem. 1997, 32, 183.
111. Gachet, C. Thromb. Haemost. 2001, 86, 222.
112. Jiang, L.-H., MacKenzie, A.B., North, R.A., Surprenant, A. Mol. Pharmacol. 2000, 58, 82.
113. Ingall, A.H., Dixon, J., Bailey, A., Coombs, M.E., Cox, D., McInally, J.I., Hunt, S.F., Kindon, N.D., Teobald, B.J., Willis, P.A., Humphries, R.G., Leff, P., Clegg, J.A., Smith, J.A., Tomlinson, W. J. Med. Chem. 1999, 42, 213.
114. Lambrecht, G., Rettinger, J., Bäumert, H.G., Czeche, S., Damer, S., Ganso, M., Hildebrandt, C., Niebel, B., Spatz-Kümbel, G., Schmalzing, G., Mutschler, E. Eur. J. Pharmacol. 2000, 387, R19.
115. Kim, Y.-C., Brown, S.G., Harden, T.K., Boyer, J.L., Dubyak, G., King, B.F., Burnstock, G., Jacobson, K.A. J. Med. Chem. 2001, 44, 340.
116. Layton, D., Azzi, A. Biochem. Biophys. Res. Commun. 1974, 59, 322.
117. Emmic, J.T., Kwon, S., Bidasee, K.R., Besch, K.T., Besch Jr., H.R., J. Pharmacol. Exp. Ther. 1994, 269, 717.
118. Heider, P. Thesis, University of Frankfurt/M., Germany, 1992.
119. Lambrecht, G., Ardanuy, U., Bäumert, H.G., Bo, X., Hoyle, C.H.V., Nickel, P., Pfaff, O., Ralevic, V., Windscheif, U., Ziganshin, A.U., Ziyal, R., Mutschler, E., Burnstock, G. In Perspective in Receptor Research, Giardiná, Piergentili, Pigini, Eds., Elsevier Science B.V.: Amsterdam, 1996, pp. 337-350.
120. Lambrecht, G., Friebe, T., Grimm, U., Windscheif, U., Bungardt, E., Hildebrandt, C., Bäumert, H.G., Spatz-Kümbel, G., Mutschler, E. Eur. J. Pharmacol. 1992, 217, 217.
121. Lambrecht, G. J. Auton. Pharmacol. 1996, 16, 341.
122. Windscheif, U., Pfaff, O., Ziganshin, A.U., Hoyle, C.H.V., Bäumert, H.G., Mutschler, E., Burnstock, G., Lambrecht, G. Br. J. Pharmacol. 1995, 115, 1509.
123. Windscheif, U., Ralevic, V., Bäumert, H.G., Mutschler, E., Lambrecht, G., Burnstock, G. Br. J. Pharmacol. 1994, 113, 1015.
124. McLaren, G.J., Lambrecht, G., Mutschler, E., Bäumert, H.G., Sneddon, P., Kennedy, C. Br. J. Pharmacol. 1994, 111, 913.
125. Ziganshin, A.U., Hoyle, C.H.V., Bo, X., Lambrecht, G., Mutschler, E., Bäumert, H.G., Burnstock, G. Br. J. Pharmacol. 1993, 110, 1491.
126. Ziganshin, A.U., Hoyle, C.H.V., Lambrecht, G., Mutschler, E., Bäumert, H.G., Burnstock, G. Br. J. Pharmacol. 1994, 111, 923.
127. Windscheif, U., Radziwon, P., Breddin, H.K., Bäumert, H.G., Lambrecht, G., Mutschler, E. Arzneim.-Forsch./Drug Res. 1995, 45, 994.
128. Buell, G., Lewis, C., Collo, G., North, R.A., Surprenant, A. EMBO J. 1996, 15, 55.
129. Collo, G., North, R.A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A., Buell, G. J. Neurosci. 1996, 16, 2495.
130. Trezise, D.J., Bell, N.J., Khakh, B.S., Michel, A.D., Humprey, P.P.A. Eur. J. Pharmacol. 1994, 259, 295.
131. Westfall, T.D., McIntyre, C.A., Obeid, S., Bowes, J., Kennedy, C., Sneddon P. Br. J. Pharmacol. 1997, 121, 57.
132. Sneddon, P., Westfall, T.D., Todorov, L.D., Todorova, S.M., Westfall, D.P., Nickel, P., Kennedy, C. Br. J. Pharmacol. 2000, 129, 1089.
133. Wang, X., Dakshinamurti, K., Musat, S., Dhalla, N.S. J. Mol. Cell. Cardiol. 1999, 31, 1063.
134. Bültmann, R., Dudeck, O., Starke, K. Naunyn-Schmiedeberg's Arch. Pharmacol. 1996, 353, 445.
135. Connolly, G.P. Br. J. Pharmacol. 1995, 114, 727.
136. Grimm, U., Fuder, H., Moser, U., Bümert, H.G., Mutschler, E., Lambrecht, G. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 349, 1.
137. Hansmann, G., Bültmann, R., Tuluc, F., Starke, K. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 356, 641.
138. Khakh, B.S., Michel, A., Humphrey, P.P.A. Eur. J. Pharmacol. 1994, 263, 301.
139. Fröhlich, R., Boehm, S., Illes, P. Eur. J. Pharmacol. 1996, 315, 255.
140. Neely, C.F., Matot, I., Batra, V.K., Bo, X., Burnstock, G. Am. J. Physiol. 1996, 270, L889.
141. Peoples, R.W., Li, C. Br. J. Pharmacol. 1998, 124, 400.
142. van der Giet, M., Jankowski, J., Schlüter, H., Zidek, W., Tepel, M. J. Hypertens. 1998, 16, 1939.
143. Heine, P., Braun, N., Heilbronn, A., Zimmermann, H. Eur. J. Biochem. 1999, 262, 102.
144. Ziganshin, A.U., Ziganshina, L.E., King, B.F., Pintor, J., Burnstock, G. Biochem. Pharmacol. 1996, 51, 897.
145. Hoffmann, C., Heine, P., Pradel, G., Kim, Y.-C., Jacobson, K.A., Zimmermann, H. Drug Dev. Res. 2000, 51, 153.
146. Jacobson, K.A., Kim, Y.-C., Wildman, S.S., Mohanram, A., Harden, T.K., Boyer, J.L., King, B.F., Burnstock, G. J. Med. Chem. 1998, 41, 2201.
147. Kim, Y.-C., Camaioni, E., Ziganshin, A.U., Ji, X.-d., King, B.F., Wildman, S.S., Rychkov, A., Yoburn, J., Kim, H., Mohanram, A., Harden, T.K., Boyer, J.L., Burnstock, G., Jacobson, K.A. Drug Dev. Res. 1998, 45, 52.
148. Halazy, S. Exp. Opin. Ther. Patents 1999, 9, 431.
149. Portoghese, P.S. J. Med. Chem. 2001, 44, 2259.
150. Lambrecht, G., Ganso, M, Bäumert, H.G., Spatz-Kümbel, G., Hildebrandt, C., Braun, K., Mutschler, E. J. Auton. Nerv. Sys. 2000, 81, 171.
151. Baghdiguian S., Fantini, J. Cancer J. 1997, 10, 31.
152. Voogd, T.E., Vansterkenburg, E.L.M., Wilting, J., Janssen, L.H.M. Pharmacol. Rev. 1993, 45, 177.
153. Grossman, S.A., Phuphanich, S., Lesser, G., Rozental, J., Grochow, L.B., Fisher, J., Piantadosi, S. J. Clin. Oncol, 2001, 19, 3260.
154. Chijioke, C.P., Umeh, R.E., Mbah, A.U., Nwonu, P., Fleckenstein, L.L., Okonkwo, P.O. Eur. J. Clin. Pharmacol. 1998, 54, 249.
155. McNally, W.P., DeHart, P.D., Lathia, C., Whitfield, L.R. Life Sci. 2000, 67, 1847.
156. Beukers, M.W., Kerkof, C.J.M., van Rhee, M.A., Ardanuy, U., Gurgel, C., Widjaja, H., Nickel, P., IJzerman, A.P., Soudijn, W. Naunyn-Schmiedeberg's Arch. Pharmacol. 1995, 351, 523.
157. Hourani, S.M.O., Hall, D.A., Nieman, C.J. Br. J. Pharmacol. 1992, 105, 453.
158. Oesterle, R., Jurkiewicz, E., Lücke, W., Nickel, P., Hunsmann, G., Jentsch, K.D. Antiviral Res. 1993, 22, 107.
159. Firsching-Hauck, A., Nickel, P., Yahya, C., Wandt, C., Kulik, R., Simon, N., Zink, M., Nehls, V., Allolio, B. Anti-Cancer Drugs 2000, 11, 69.
160. Gagliardi, A.R.T., Kassack, M., Kreimeyer, A., Muller, G., Nickel, P., Collins, D.C. Cancer Chemother. Pharmacol. 1998, 41, 117.
161. Braddock, P.S., Hu, D.-E., Fan, T.-P.D., Stratford, I.J., Harris, A.L., Bicknell, R. Br. J. Cancer 1994, 69, 890.
162. Kassack, M. U. Exp. Opin. Ther. Patents 2000, 10, 917.
163. Strassmann, G., D'Alessandro, F., Fong, M., Nordan, R.P., Nickel, P., Chizzonite, R. Int. J. Immunopharmac. 1994, 16, 931.
164. Freissmuth, M., Boehm, S., Beindl, W., Nickel, P., IJzerman, A.P., Hohenegger, M., Nanoff, C. Mol. Pharmacol. 1996, 49, 602.
165. Dunn, P.M., Blakeley, A.G.H. Br. J. Pharmacol. 1988, 93, 243.
166. Bültmann, R., Wittenburg, H., Pause, B., Kurz, G., Nickel, P., Starke, K. Naunyn-Schmiedeberg's Arch. Pharmacol. 1996, 354, 498.
167. Bültmann, R., Klebroff, W., Starke, K. Naunyn-Schmiedeberg's Arch. Pharmacol. 1999, 360, 196.
168. Lê, K.-T., Babinski, K., Séguéla, P. J. Neurosci. 1998, 18, 7152.
169. Bianchi, B.R., Lynch, K.J., Touma, E., Niforatos, W., Burgard, E.C., Alexander, K.M., Park, H.S., Yu, H., Metzger, R., Kowaluk, E., Jarvis, M.F., van Biesen, T. Eur. J. Pharmacol. 1999, 376, 127.
170. Haines, W.R., Torres, G.E., Voigt, M.M., Egan, T.M. Mol. Pharmacol. 1999, 58, 720.
171. Damer, S., Niebel, B., Czeche, S., Nickel, P., Ardanuy, U., Schmalzing, G., Rettinger, J., Mutschler, E., Lambrecht, G. Eur. J. Pharmacol. 1998, 350, R5.
172. Soto, F., Lambrecht, G., Nickel, P., Stühmer, W., Busch, A.E. Neuropharmacology 1999, 38, 141.
173. Rettinger, J., Schmalzing, G., Damer, S., Müller, G., Nickel, P., Lambrecht, G. Neuropharmacology 2000, 39, 2044.
174. Klapperstück, M., Büttner, C., Nickel, P., Schmalzing, G., Lambrecht, G., Markwardt, F. Eur. J. Pharmacol. 2000, 387, 245.
175. Urbanek, E., Nickel, P., Schlicker, E. Eur. J. Pharmacol. 1990, 175, 207.
176. Ziyal, R., Ziganshin, A.U., Nickel, P., Ardanuy, U., Mutschler, E., Lambrecht, G., Burnstock, G. Br. J. Pharmacol. 1997, 120, 954.
177. Ziyal, R., Ralevic, V., Ziganshin, A.U., Nickel, P., Ardanuy, U., Mutschler, E., Lambrecht, G., Burnstock, G. Drug Dev. Res. 1996, 37, 113.
178. Harper, S. Webb, T.E., Charlton, S.J., Ng, L.L., Boarder, M.R. Br. J. Pharmacol. 1998, 124, 703.
179. Beindl, W., Mitterauer, T., Hohenegger, M., IJzerman, A.P., Nanoff, C., Freissmuth, M. Mol. Pharmacol. 1996, 50, 415.
180. Hohenegger, M., Waldhoer, M., Beindl, W., Böing, B., Kreimeyer, A., Nickel, P., Nanoff, C., Freissmuth, M. Proc, Natl. Acad. Sci. USA 1998, 95, 346.
181. Boeynaems, J.-M., Robaye, B., Janssens, R., Suarez-Huerta, N., Communi, D. Drug Dev. Res. 2001, 52, 187.
182. Abbracchio, M.P., Burnstock, G. Jpn. J. Pharmacol. 1998, 78, 113.
183. Williams, M., Jarvis, M.F. Biochem. Pharmacol. 2000, 59, 1173.
184. Burnstock, G., Williams, M. J. Pharmacol. Exp. Ther. 2000, 295, 862.
185. Storey, R.F. Drug Dev: Res. 2001, 52, 202.
186. Storey, R.F., Oldroyd, K.G., Wilcox, R.G. Thromb. Haemost. 2001, 85, 401.
187. Storey, R.F. Platelets 2001, 12, 197.
188. Kikuta, Y., Ohiwa, E., Okada, K., Watanabe, A., Haruki, S. Acta Anaesthesiol. Scand. 1999, 43, 82.
189. Steinmetz, M., van Le, T., Hollah, P., Gabriëls, G., Hohage, H., Rahn, K.H., Schlatter, E. J. Pharmacol. Exp. Ther. 2000, 294, 963,
190. Gabriëls, G., Endlich, K., Rahn, K.H., Schlatter, E., Steinhausen, M. Kidney Int. 2000, 57, 2476.
191. Masaki, E., Ebisawa, T., Kondo, I., Hayashida, K., Matsumoto, Y., Kawamura, M. Brain Res. 2000, 864, 130.
192. Pintor, J., Peral, A. Drug Dev. Res. 2001, 52, 190.
193. Yerxa, B.R. Drug Dev. Res. 2001, 52, 196.
194. Fujihara, T., Murakami, T., Fujita, H., Nakamura, M., Nakata, K. Invest. Ophthalmol. Vis. Sci. 2001, 42, 96.
195. Hillaire-Buys, D., Bertrand, G., Chapal, J., Puech, R., Ribes, G., Loubatiéres-Mariani, M.M. Br. J. Pharmacol. 1993, 109, 183.
196. Zimmermann, H. Drug Dev. Res. 2001, 52, 44.
197. Burnstock, G. Drug Dev. Res. 2001, 52, 1.
198. Jarvis, M.F., Kowaluk, E.A. Drug Dev. Res. 2001, 52, 220.
199. Ho, B.T., Huo, Y.Y., Lu, J.G., Newman, R.A., Levin, V.A. Anti-Cancer Drugs 1992, 3, 91.
200. Burnstock, G. Drug Dev. Res. 1998, 45, 86.
201. Calvert, R.C., Thompson, C.S., Khan, M.A., Mikhailidis, D.P., Morgan, R.J., Burnstock, G. J. Urol. 2001, 166, 1530.
202. Boarder, M.R., Hourani, S.M.O. Trends Pharmacol. Sci. 1998, 19, 99.
203. Dunn, P.M. Curr. Biol. 2000, 10, R305.
204. Di Virgilio, F., Falzoni, S., Mutini, C., Sanz, J.M., Chiozzi, P. Drug Dev. Res. 1998, 45, 207.
205. Gachet, C. Ann. Med. 2000, 32 Suppl. 1, 15.
206. Jarvis, B., Simpson, K. Drugs 2000, 60, 347.
207. Kunapuli, S.P. Drug Dev. Res. 1998, 45, 135.
208. Kunapuli, S.P. Trends Pharmacol. Sci. 1998, 19, 391.
209. Cusack, N.J., Hourani, S.M.O. J. Auton. Nerv. Sys. 2000, 81, 37.
210. Foster, C.J., Prosser, D.M., Agans, J.M., Zhai, Y., Smith, M.D., Lachowicz, J.E., Zhang, F.L., Gustafson, E., Monsma, Jr., F.J., Wiekowski, M.T., Abbondanzo, S.J., Cook, D.N., Bayne, M.L., Lira, S.A., Chintala, M.S. J. Clin. Invest. 2001, 107, 1591.
211. Greco, N.J., Tonon, G., Chen, W., Luo, X., Dalal, R., Jamieson, G.A. Blood 2001, 98, 100.
212. Lewis, C.J., Davies, N.W., Evans, R.J. Drug Dev. Res. 2001, 52, 164.
213. Vial, C., Evans, R.J. Auton. Neurosci. Basic Clin. 2001, 92, 56.
214. Dixon, S.J., Sims, S.M. Drug Dev. Res. 2000, 49, 187.
215. Yoshida, M., Homma, Y., Inadome, A., Yono, M., Seshita, H., Miyamoto, Y., Murakami, S., Kawabe, K., Ueda, S. Exper. Gerontol. 2001, 36, 99.
216. Leff, P., Wood, B.E., O'Connor, S.E., McKechnie, K. Br. J. Pharmacol. 1993, 108, 490.
217. Frith, J.C., Mönkkönen, J., Blackburn, G.M., Russell, R.G.G., Rogers, M.J. J. Bone Miner. Res. 1997, 12, 1358.
218. Hoebertz, A., Meghji, S., Burnstock, G., Arnett, T.R. FASEB J. 2001, 15, 1139.
219. Zimmermann, H. Prog. Neurobiol. 1996, 49, 589.
220. Zimmermann, H. In Purinergic and Pyrimidinergic Signalling I. Handbook of Experimental Pharmacology, Abbracchio, Williams, Eds., Springer-Verlag: Berlin, 2001, Vol. 151/I, pp. 209-250.